References
- 1. STEIN PD, HULL RD, GHALI WA, PATEL KC, OLSON RE, MEYERS FA, et al. Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism. Arch. Intern. Med. 2003; 163 (10):1213-9.
- 2. JA H. The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management. Journal of Thrombosis and Thrombolysis. 2006; 21 (1):23-9.
- 3. GOLDHABER SZ, VISANI L. The International Cooperative Pulmonary Embolism Registry. Chest. 1995; 108 (2):302-4.
- 4. BAUMANN KREUZIGER L, COTE L, VERHAMME P, GREENBERG S, CAPRINI J, MUNOZ FJ, et al. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis. Journal of vascular surgery. Venous and lymphatic disorders. 2015; 3 (3):243-50. e1.
- 5. AO. PETRIS GT-C, A. NECHITA, C. POP, M. VLADOIANU, L. PETRESCU, L. VIDA-SIMITI, D. TINT, D. CIMPOESU. Pulmonary embolism with and without acute heart failure: what makes the difference? Data from Romanian registry for pulmonary thromboembolism (RO-TEP). European Journal of HEart Failure Suppl. 2013:S267.
- 6. ZAMORANO JL, ACHENBACH S, BAUMGARTNER H, BAX JJ, BUENO H, DEAN V, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the European Respiratory Society (ERS). Eur. Heart J. 2014; 35 (43):3033-73.
- 7. OGENG'O JA, OBIMBO MM, OLABU BO, GATONGA PM, ONG'ERA D. Pulmonary thromboembolism in an East African tertiary referral hospital. J. Thromb. Thrombolysis. 2011; 32 (3):386-91.
- 8. SCHISSLER AJ, ROZENSHTEIN A, SCHLUGER NW, EINSTEIN AJ. National trends in emergency room diagnosis of pulmonary embolism, 2001–2010: a cross-sectional study. Respir. Res. 2015; 16 (1):44.
- 9. SHEN J-H, CHEN H-L, CHEN J-R, XING J-L, GU P, ZHU B-F. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J. Thromb. Thrombolysis. 2016; 41 (3):482-92.
- 10. HEIT JA. Epidemiology of venous thromboembolism. Nature reviews. Cardiology. 2015; 12 (8):464-74.
- 11. GREEN RM, MEYER TJ, DUNN M, GLASSROTH J. Pulmonary embolism in younger adults. Chest. 1992; 101 (6):1507-11.
- 12. NIELSEN OW, HILDEN J, LARSEN CT, HANSEN JF. Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk. Heart. 2001; 86 (2):172-8.
- 13. TORRE LA, SIEGEL RL, WARD EM, JEMAL A. Global Cancer Incidence and Mortality Rates and Trends - An Update. Cancer Epidemiol. Biomarkers Prev. 2016; 25 (1):16-27.10.1158/1055-9965.EPI-15-0578
- 14. JANATA K, HOLZER M, DOMANOVITS H, MULLNER M, BANKIER A, KURTARAN A, et al. Mortality of patients with pulmonary embolism. Wiener klinische Wochenschrift. 2002; 114 (17-18):766-72.
- 15. GOLDHABER SZ, VISANI L, DE ROSA M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999; 353 (9162):1386-9.
- 16. POLLACK CV, SCHREIBER D, GOLDHABER SZ, SLATTERY D, FANIKOS J, O'NEIL BJ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J. Am. Coll. Cardiol. 2011; 57 (6):700-6.10.1016/j.jacc.2010.05.071
- 17. MARGOLIS JM, DEITELZWEIG S, KLINE J, TRAN O, SMITH DM, BOOKHART B, et al. Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2016; 5 (10):e003788.
- 18. ROBERTS KM, KNIGHT TB, PADILLA-TOLENTINO E, MURTHY M, PETERSON EJ. Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study. Thrombosis. 2015; 2015:6.
- 19. INVESTIGATORS TEP. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism. N. Engl. J. Med. 2012; 366 (14):1287-97.
- 20. AGNELLI G, BULLER HR, COHEN A, CURTO M, GALLUS AS, JOHNSON M, et al. Oral Apixaban for the Treatment of Acute Venous Thromboembolism. N. Engl. J. Med. 2013; 369 (9):799-808.
- 21. HANSLIK T, PRINSEAU J. The use of vitamin K in patients on anticoagulant therapy: a practical guide. Am. J. Cardiovasc. Drugs. 2004; 4 (1):43-55.